Literature DB >> 17327736

Hemodynamic manipulation in the neuro-intensive care unit: cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm.

Michael N Diringer1, Yekaterina Axelrod.   

Abstract

PURPOSE OF REVIEW: The intent of this manuscript is to summarize the pathophysiologic basis for hemodynamic manipulation in subarachnoid hemorrhage and traumatic brain injury, highlight the most recent literature and present expert opinion on indications and use. RECENT
FINDINGS: Hemodynamic augmentation with vasopressors and inotropes along with hypervolemia are the mainstay of treatment of vasospasm due to subarachnoid hemorrhage. Considerable variation continues to exist regarding fluid management and the use of vasopressors and inotropes. Blood pressure augmentation, volume expansion and cardiac contractility enhancement improve cerebral blood flow in ischemic areas, ameliorate vasospasm and improve clinical condition. In patients suffering from severe traumatic brain injury, while every attempt is made to control intracranial hypertension, cerebral perfusion-directed therapy with fluids and vasopressors is also used to keep cerebral perfusion pressure above 60-70 mmHg. Yet, recent observations suggest that posttraumatic mitochondrial dysfunction has been proposed as an alternative explanation for lower cerebral blood flow after acute trauma.
SUMMARY: Hemodynamic manipulation is routinely used in the management of patients with acute vasospasm following subarachnoid hemorrhage and severe head injury. The rationale is to improve blood flow to the injured brain and prevent secondary ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327736     DOI: 10.1097/MCC.0b013e32807f2aa5

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  6 in total

1.  Ameliorating effects of Kangen-karyu on neuronal damage in rats subjected to repeated cerebral ischemia.

Authors:  Fengling Pu; Tomohiro Kaneko; Makiko Enoki; Keiichi Irie; Takuya Okamoto; Yasuo Sei; Nobuaki Egashira; Ryozo Oishi; Kenichi Mishima; Hidetoshi Kamimura; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  J Nat Med       Date:  2010-02-13       Impact factor: 2.343

Review 2.  Management of aneurysmal subarachnoid hemorrhage.

Authors:  Michael N Diringer
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

3.  Differing effects when using phenylephrine and norepinephrine to augment cerebral blood flow after traumatic brain injury in the immature brain.

Authors:  Stuart H Friess; Benjamin Bruins; Todd J Kilbaugh; Colin Smith; Susan S Margulies
Journal:  J Neurotrauma       Date:  2014-11-24       Impact factor: 5.269

4.  Norepinephrine as a potential aggravator of symptomatic cerebral vasospasm: two cases and argument for milrinone therapy.

Authors:  F A Zeiler; J Silvaggio; A M Kaufmann; L M Gillman; M West
Journal:  Case Rep Crit Care       Date:  2014-11-09

5.  Early detection of nonneurologic organ failure in patients with severe traumatic brain injury: Multiple organ dysfunction score or sequential organ failure assessment?

Authors:  Sara Ramtinfar; Shahrokh Yousefzadeh Chabok; Aliakbar Jafari Chari; Zoheir Reihanian; Ehsan Kazemnezhad Leili; Arsalan Alizadeh
Journal:  Indian J Crit Care Med       Date:  2016-10

6.  Effect of inotropic agents on oxygenation and cerebral perfusion in acute brain injury.

Authors:  Giacomo Coppalini; Elie Duvigneaud; Alberto Diosdado; Ernesto Migliorino; Sophie Schuind; Jacques Creteur; Fabio Silvio Taccone; Elisa Gouvêa Bogossian
Journal:  Front Neurol       Date:  2022-07-19       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.